tirzepatide surpass-4 Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Effects of tirzepatide versus insulin

26 The next generation of GLP-1 receptor agonists has a dual action mechanism, targeting both GLP-1 and glucose-dependent insulinotropic peptide (GIP) receptors, and shows greater efficacy for weight loss

Rathore SS, Ordin DL, Krumholz HM

Non-Injectable Peptides for Weight Loss: What Actually Exists There are legitimate oral options and there are marketing options, and it helps to separate them

Many men have tried traditional ED treatments that improve blood flow but still find that desire itself is diminished especially with age, stress, or fatigue

You can also report suspected side effects directly to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk)